Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, March 29, 2024 | Back issues
Courthouse News Service Courthouse News Service

OxyContin Patent

MANHATTAN - A generic version of the blockbuster drug OxyContin did not infringe on Purdue Pharma's patent, a federal judge ruled, siding with the patent invalidity defense put forward by Teva Pharmaceuticals.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...